Chaparro, M, Hermida, S, Martín, LZS, Cuquerella, JT, de Castro, L, Domínguez, CL, Rodríguez-Lago, I, Castro, CR, Trastoy, PV, Gargallo-Puyuelo, CJ, Abadía, PR, Ruiz-Cerulla, A, Acosta, MBD, de Francisco, R, Gutiérrez, A, Jiménez, N, Villarroya, RP, Bujanda, L, Martínez, AMT, García, LA, Camero, RC, Calafat, M, Palomares, MTDL, Andrés, PR, Sampedro, MJ, Nieto, YB, Bermejo, F, Moya, MC, Casanova, MJ, Ceballos, D, Martín-Rodríguez, D, Mesonero, F, Zabana, Y, Crespo, AS, Sierra-Ausín, M, Caballol, B, Luengo, MC, Giordano, A, Domènech, E, Gisbert, JP, U REAL UC Study Grp ENEIDA. Effectiveness and safety of upadacitinib in ulcerative colitis in clinical practice: results from the U-REAL-UC study from ENEIDA. Journal of Crohns & Colitis. 2025; 19DOI:10.1093/ecco-jcc/jjae190.0838. PMID:. IF:8.700(Q1/1D).

Marquès-Cami, M, Vergés, L, Caballero-Mateos, AM, Carvaca, C, Suárez-Ferrer, C, Carballo-Folgoso, L, Carballal, A, Roig, C, Fernández-Clotet, A, Moreno,, Tejido, C, Brunet-Mas, E, Torres, G, Huguet, JM, San-Román, C, Benítez, JM, Zabana, Y, Young Grp GETECCU. Comparative analysis between capsule endoscopy and ileocolonoscopy for activity detection in ileal Crohn's disease. Preliminary results from the CAPITER study, a multicenter study from the Young Group of GETECCU. Journal of Crohns & Colitis. 2025; 19DOI:10.1093/ecco-jcc/jjae190.0609. PMID:. IF:8.700(Q1/1D).

Chaparro, M, Hermida, S, Camero, RC, Abadía, PR, Vela-González, M, Casanova, MJ, de Castro, L, Gargallo-Puyuelo, CJ, García, LA, de Francisco, R, San Martín, LZ, Barreiro-de Acosta, M, Cuquerella, JT, Lago, IR, Moya, MC, Domínguez, CL, Villarroya, RP, Andrés, PR, Calafat, M, Gutiérrez, A, Pascual, CM, Crespo, AS, Caballol, B, Sierra-Ausín, M, Poceiro, JC, Giordano, A, Huguet, JM, Manzano, MAM, Castro, CR, Ruiz-Cerulla, A, Almela, P, Martínez, AMT, Senosiain, BC, Flores, EI, Martín-Rodríguez, D, Trastoy, PV, Ceballos, D, Palomares, MTDL, Domènech, E, Gisbert, JP, SET UP UC Study Grp GETECCU. Comparing JAK inhibitors in ulcerative colitis: which one truly leads in the real world? Results from the ENEIDA registry of GETECCU. Journal of Crohns & Colitis. 2025; 19DOI:10.1093/ecco-jcc/jjae190.0866. PMID:. IF:8.700(Q1/1D).

Ukashi, O, Amiot, A, Laharie, D, Menchén, L, Gutierrez, A, Fernandes, S, Pessarelli, T, Correia, F, Gonzalez-Muñoza, C, López-Cardona, J, Acosta, MBD, Yanai, H, Armuzzi, A, Magro, F, Kopylov, U. Inter-rater disagreements in applying the Montreal classification for Crohn's disease: The Five-Nations Survey Study. Journal of Crohns & Colitis. 2025; 19DOI:10.1093/ecco-jcc/jjae190.0425. PMID:. IF:8.700(Q1/1D).

Sard, MC, Mañosa, M, Fernández-Clotet, A, Pasanau, L, Matallana,, Iglesias, E, Hernández-Camba, A, Ucha, P, Nos, P, Barrio, J, Gutiérrez, A, Merino,, Barreiro-de Acosta, M, Cudero, L, Casanova, MJ, González-Muñoza, C, Bujanda, L, Varela, P, Bermejo, F, Torres, N, Mesonero, F, Calvet, X, Rivas, C, Perez, C, Alonso-Abreu,, Rodríguez-Lago,, Vega, P, Zabana, Y, Mora, M, Busquets, D, Rodríguez-Gutiérrez, C, Torres, G, Valldosera, G, Ponferrada, A, Ceballos, D, Pascual, CM, Jiménez, N, Sampedro, M, Irabien, M, Domènech, E, ENEIDA registry, GETECCU. Postoperative recurrence after a definitive ostomy in Crohn's disease. A nationwide retrospective series from the Eneida registry. Journal of Crohns & Colitis. 2025; 19DOI:10.1093/ecco-jcc/jjae190.0400. PMID:. IF:8.700(Q1/1D).

Oomens, JE, van Gils, V, Vos, SJB, Freeze, WM, Maserejian, NN, Curiale, G, Gillis, C, Boada, M, van der Flier, WM, Hort, J, Johnson, SC, Lleo, A, Ramakers, IH, Rodrigue, KM, Sanchez-Juan, P, Sarazin, M, Scarmeas, N, Zetterberg, H, Alcolea, D, Barkhof, F, Blennow, K, Bottlaender, M, den Braber, A, Cerman, J, Drake-Perez, M, Fortea, J, Handels, R, Ingala, S, Jimenez-Bonilla, JF, Karavasilis, S, Lagarde, J, Legdeur, N, Lorenzini, L, Marquie, M, Moonen, JEF, Olivieri, P, Orellana, A, Ossenkoppele, R, Rivera-Rivera, LA, Rodriguez-Rodriguez, E, Laza, AR, Teunissen, CE, Tijms, BM, Velonakis, G, Verhey, FRJ, Visser, PJ, Jansen, WJ. Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker Study. JAMA Network Open. 2025; 8(1)DOI:10.1001/jamanetworkopen.2024.55571. PMID:39841474. IF:9.700(Q1/1D).